Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Braveheart Bio, Inc. (BRVE) had Return on Tangible Equity of 100.27% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-66.05M |
|
-- |
|
-- |
|
$66.75M |
|
$-66.75M |
|
$0.70M |
|
$-66.05M |
|
$-66.05M |
|
$-66.05M |
|
$-66.05M |
|
$-66.05M |
|
$-66.05M |
|
$-66.75M |
|
$-66.75M |
|
3.84M |
|
3.84M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$89.28M |
|
-- |
|
$0.07M |
|
$89.35M |
|
$5.24M |
|
-- |
|
$149.98M |
|
$155.22M |
|
$-65.87M |
|
$-65.87M |
|
$-65.87M |
|
6.69M |
|
| Cash Flow Statement Financials | |
$-2.01M |
|
$-33.57M |
|
$124.74M |
|
-- |
|
$89.16M |
|
$89.16M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.27% |
|
|
Return on Tangible Equity |
100.27% |
-73.92% |
|
100.27% |
|
$-9.85 |
|
$-0.52 |
|
$-0.52 |
|